Clinical Presentation and Management of Prostate Cancer in the Middle East

被引：0

作者：

Sayan, M. ^{[1
]}

Aynaci, O. ^{[2
]}

Eren, A. Ay ^{[3
]}

Eren, M. F. ^{[4
]}

Kazaz, I. O. ^{[5
]}

Ibrahim, Z. ^{[6
]}

Al-Akelie, O. T. ^{[7
]}

Al-Mansouri, L. ^{[8
]}

Abuhijlih, R. ^{[9
]}

Moningi, S. ^{[1
,10
,11
]}

El Eajj, A. ^{[12
]}

Mula-Hussain, L. ^{[13
]}

Orio, P. F., III ^{[14
,15
]}

机构：

[1] Dana Farber Canc Inst, Boston, MA USA

[2] Karadeniz Tech Univ, Trabzon, Turkiye

[3] Kartal Dr Lutfi Kirdar Educ & Res Hosp, Istanbul, Turkiye

[4] Marmara Univ Hastanesi, Istanbul, Turkiye

[5] Karadeniz Tech Univ, Trabzon, Turkiye

[6] King Hamad Univ Hosp, Al Sayh, Bahrain

[7] Alamal Natl Hosp Canc Management, Baghdad, Iraq

[8] Basrah Med Coll, Basra, Iraq

[9] King Hussein Canc Ctr, Amman, Jordan

[10] Brigham & Womens Hosp, Dept Radiat Oncol, Boston, MA USA

[11] Dana Farber Canc Inst, Boston, MA USA

[12] Amer Univ Beirut, Med Ctr, Beirut, Lebanon

[13] Zhianawa Canc Ctr, Sulaymaniyah, Iraq

[14] Brigham & Womens Hosp, Dept Radiat Oncol, Boston, MA USA

[15] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2023年 / 117卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2946

引用

页码：E433 / E433

页数：1

共 50 条

[21] Survey on the practice of active surveillance for prostate cancer from the Middle East
El Sebaaly, Ralph
Mansour, Mazen
Labban, Muhieddine
Jaafar, Rola F.
Armache, Alexandre
Mukherji, Deborah
El Hajj, Albert
PROSTATE INTERNATIONAL, 2020, 8 (01) : 41 - 48
[22] Validation of Epstein criteria of insignificant prostate cancer in Middle East patients
Hekal, Ihab A.
El-Tabey, Nasr A.
Nabeeh, Mohamed Adel
El-Assmy, Ahmed
Abd El-Hameed, Mohamed
Nabeeh, Adel
Ibrahiem, Elhousseiny I.
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2010, 42 (03) : 667 - 671
[23] Clinical Assessment and Management of Spondyloarthritides in the Middle East: A Multinational Investigation
Hammoudeh, Mohammed
Al Rayes, Hanan
Alawadhi, Adel
Gado, Kamel
Shirazy, Khalid
Deodhar, Atul
INTERNATIONAL JOURNAL OF RHEUMATOLOGY, 2015, 2015
[24] Presentation, management, and outcomes of complications following prostate cancer therapy
Zaid, Uwais B.
McAninch, Jack W.
Glass, Allison S.
Cinman, Nadya M.
Breyer, Benjamin N.
TRANSLATIONAL ANDROLOGY AND UROLOGY, 2014, 3 (02) : 150 - 155
[25] Prostate cancer management costs vary by disease stage at presentation
Tyler R. McClintock
Eugene B. Cone
Maya Marchese
Xi Chen
Paul L. Nguyen
Maxine Sun
Quoc-Dien Trinh
Prostate Cancer and Prostatic Diseases, 2020, 23 : 564 - 566
[26] Prostate cancer management costs vary by disease stage at presentation
McClintock, Tyler R.
Cone, Eugene B.
Marchese, Maya
Chen, Xi
Nguyen, Paul L.
Sun, Maxine
Quoc-Dien Trinh
PROSTATE CANCER AND PROSTATIC DISEASES, 2020, 23 (04) : 564 - 566
[27] Factors Influencing Late Presentation for Breast Cancer in the Middle East: A Systematic Review
Alhurishi, Sultana
Lim, Jennifer N. W.
Potrata, Barbara
West, Robert
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2011, 12 (06) : 1597 - 1600
[28] Vanishing prostate cancer. Clinical presentation and histological review
Ebel Sepulveda, Luis
Corti, Dante
Foneron, Andonico
Troncoso, Luis
Gil, Gonzalo
Carpio, Daniel
Canoles, Raul
Hornig, Alvaro
Valdevenito, Gonzalo
ACTAS UROLOGICAS ESPANOLAS, 2009, 33 (09): : 956 - 959
[29] Atypical initial clinical presentation of a prostate cancer with normal PSA
Tsoukalas, N.
Tolia, M.
Toutziaris, C.
Papakostidi, A.
Panopoulos, C.
Barbati, K.
Efremidis, A.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2011, 78 : S27 - S27
[30] Changing presentation of prostate cancer in a UK population – 10 year trends in prostate cancer risk profiles in the East of England
D C Greenberg
K A Wright
A Lophathanon
K R Muir
V J Gnanapragasam
British Journal of Cancer, 2013, 109 : 2115 - 2120

← 1 2 3 4 5 →